Market revenue in 2024 | USD 2,035.0 million |
Market revenue in 2030 | USD 3,276.5 million |
Growth rate | 8.4% (CAGR from 2025 to 2030) |
Largest segment | Pharmaceuticals |
Fastest growing segment | Biologics |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biologics, Pharmaceuticals, Medicated Feed Additives |
Key market players worldwide | Zoetis Inc Class A, Boehringer Ingelheim, Merck & Co Inc, Elanco Animal Health Inc, Dechra Pharmaceuticals, Ceva Santé Animale, Phibro Animal Health Corp Class A, Virbac SA, Bimeda Ireland, Biogenesis Bago |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary medicine market will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 72.48% in 2024. Horizon Databook has segmented the Japan veterinary medicine market based on biologics, pharmaceuticals, medicated feed additives covering the revenue growth of each sub-segment from 2018 to 2030.
The veterinary medicine market in Japan is anticipated to witness steady growth owing to the increasing number of cattle farms. The increasing livestock population is anticipated to drive market growth. In addition, growing pet healthcare expenditure and pet adoption in Japan are expected to drive the market.
For instance, Japan is the only other country in the world where pets outnumber children. According to the Japan Pet Food Association, there are over 20 million cats and dogs in the country and 17 million children under the age of 16 years. Government support and regulation for the welfare of animal health are anticipated to fuel the market in Japan.
For instance, Japan's Act of Welfare and Management of Animals (1973) focuses on building awareness among people as part of its process of implementation. Thus, growing awareness is expected to fuel the demand for veterinary medicine in the country, thereby boosting the market.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan veterinary medicine market , including forecasts for subscribers. This country databook contains high-level insights into Japan veterinary medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account